Enhancing Diversity and Addressing Disparities at the 7th Cancer Cachexia Conference

摘要 该提案要求部分支持由癌症组织的第七届癌症恶病质会议 恶病质协会（CCS），将于2023年9月28日至30日在苏格兰爱丁堡举行。的此次迭代 会议之前在波士顿、蒙特利尔、华盛顿、费城和两个虚拟版本举行 在COVID期间。会议系列的长期目标是促进研究、认识和理解 癌症恶病质的科学家，临床医生，患者和护理人员，为了促进 识别、治疗和治愈这一主要未满足的医疗需求。事实上，恶病质引起相当大的 病人和家庭的痛苦，估计造成约30%的癌症死亡，但直到最近，恶病质， 很少在任何一次重要的癌症会议上被提及。这一系列会议有助于发展 关于癌症恶病质的认识和研究，仍然是唯一一个专门致力于这一主题。研究 在癌症恶病质是小相对于所有癌症研究，是全球性的，大致相当的研究活动 在北美、欧洲和亚洲，以及在巴西和澳大利亚的显著努力。因此，我们选择举行 在苏格兰举行的第七次会议，以促进国际访问和合作。第七届巨蟹座的目的 恶病质会议是：1 -提供一个丰富的科学计划，为参与者，同时促进网络和 新的合作。2-促进患者、护理人员、提供者和研究者之间的互动， 持久的面向患者的教育材料。3-为研究生提供培训和指导， 博士后助理和初级教员。4-在会议中扩大和发展多样性、公平性和包容性 以及更广泛的癌症恶病质研究领域。这次会议的影响将是促进进展， 在抗恶病质治疗的临床研究的增长，并加强知识，研究， 癌症恶病质的研究能力。

ABSTRACT This proposal requests partial support for the 7th Cancer Cachexia Conference organized by the Cancer Cachexia Society (CCS), to be held from September 28-30, 2023, in Edinburgh, Scotland. This iteration of the conference follows prior events in Boston, Montreal, Washington DC, Philadelphia, and two virtual versions during COVID. The long-term goal of the conference series is to foster research, awareness, and understanding of cancer cachexia among scientists, clinicians, patients, and caregivers, for the purpose of advancing identification, treatment, and cure for this major unmet medical need. Indeed, cachexia causes considerable patient and family distress and is estimated to cause some 30% of cancer deaths; yet until recently, cachexia was seldom addressed in any of the major cancer meetings. This conference series has served to help grow awareness and research around cancer cachexia and remains the only one devoted solely to this topic. Research in cancer cachexia is small relative to all cancer research and is global, with roughly equivalent research activity in North America, Europe, and Asia and notable efforts in Brazil and Australia. Hence, we have opted to hold the 7th conference in Scotland to facilitate international access and collaboration. The Aims of the 7th Cancer Cachexia Conference are to: 1 - Deliver a rich scientific program for participants while promoting networking and new collaborations. 2- Promote interaction among patients, caregivers, providers, and investigators and develop enduring patient-facing educational material. 3- Provide for training and mentorship of graduate students, postdoctoral associates, and junior faculty. 4-Expand and grow diversity, equity, and inclusion in the conference and the wider field of cancer cachexia research. The impact of this conference will be to promote progress and growth in the clinical investigation of anti-cachexia therapies and to strengthen knowledge, research, and research capacity in cancer cachexia.